论文信息 - Low Visceral Fat Content Is a Negative Predictive Marker for Bevacizumab in Metastatic Colorectal Cancer. - 字舞流文

Low Visceral Fat Content Is a Negative Predictive Marker for Bevacizumab in Metastatic Colorectal Cancer.

E. Oki | Y. Maehara | Y. Sakamoto | H. Saeki | Y. Ogata | Y. Akagi | H. Baba | Takaho Tanaka | Y. Miyamoto | S. Tokunaga | M. Shimokawa | Y. Emi